[HTML][HTML] Acellular pertussis vaccine components: today and tomorrow

KK Dewan, B Linz, SE DeRocco, ET Harvill - Vaccines, 2020 - mdpi.com
Pertussis is a highly communicable acute respiratory infection caused by Bordetella
pertussis. Immunity is not lifelong after natural infection or vaccination. Pertussis outbreaks …

[HTML][HTML] Whoop! There it is: The surprising resurgence of pertussis

AR Fullen, KS Yount, P Dubey, R Deora - PLoS pathogens, 2020 - journals.plos.org
Despite high global vaccine coverage, whooping cough, also known as pertussis, caused by
the gram-negative obligate human pathogen Bordetella pertussis (Bp), is resurging …

Prime-pull immunization of mice with a BcfA-adjuvanted vaccine elicits sustained mucosal immunity that prevents SARS-CoV-2 infection and pathology

MM Shamseldin, A Kenney, A Zani… - The Journal of …, 2023 - journals.aai.org
Vaccines against SARS-CoV-2 that induce mucosal immunity capable of preventing
infection and disease remain urgently needed. In this study, we demonstrate the efficacy of …

[HTML][HTML] Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces …

KS Yount, JM Hall, K Caution, MM Shamseldin… - Frontiers in …, 2023 - frontiersin.org
Introduction Resurgence of pertussis, caused by Bordetella pertussis, necessitates novel
vaccines and vaccination strategies to combat this disease. Alum-adjuvanted acellular …

Overcoming waning immunity in pertussis vaccines: workshop of the National Institute of Allergy and Infectious Diseases

FH Damron, M Barbier, P Dubey… - The Journal of …, 2020 - journals.aai.org
Despite high vaccine coverage in many parts of the world, pertussis is resurging in a number
of areas in which acellular vaccines are the primary vaccine administered to infants and …

[HTML][HTML] Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of …

A Saso, B Kampmann, S Roetynck - Vaccines, 2021 - mdpi.com
Pertussis ('whooping cough') is a severe respiratory tract infection that primarily affects
young children and unimmunised infants. Despite widespread vaccine coverage, it remains …

[HTML][HTML] Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections

MC Gestal, HM Johnson, ET Harvill - Frontiers in Immunology, 2019 - frontiersin.org
Well-adapted pathogens have evolved to survive the many challenges of a robust immune
response. Defending against all host antimicrobials simultaneously would be exceedingly …

[HTML][HTML] Subcutaneous Immunization of Dogs With Bordetella bronchiseptica Bacterial Ghost Vaccine

A Muhammad, J Kassmannhuber, M Rauscher… - Frontiers in …, 2019 - frontiersin.org
The Bordetella species are Gram-negative bacterial pathogens that colonizes mammalian
respiratory tract causing respiratory diseases in humans and animals. B. bronchiseptica …

Genome-based prediction of cross-protective, HLA-DR-presented epitopes as putative vaccine antigens for multiple Bordetella species

MS Natrajan, JM Hall, MR Weigand, Y Peng… - Microbiology …, 2024 - Am Soc Microbiol
Acellular pertussis vaccines protect against severe pertussis, but vaccine-induced immunity
wanes over time. Prior animal studies showed that T-cell responses are integral to long …

Development of carbohydrate based next-generation anti-pertussis vaccines

P Wang, S Ramadan, P Dubey, R Deora… - Bioorganic & medicinal …, 2022 - Elsevier
Pertussis is a highly contagious respiratory disease caused by the Gram-negative bacterial
pathogen, Bordetella pertussis. Despite high global vaccination rates, pertussis is resurging …